Keynote: Bioanalytics Future State: Precise, Personal and Predictive

Wednesday, October 19, 2022

1:30 PM – 2:30 PM ET

Location:253 A

Keynote Speaker(s)

Kevin Bateman, PhD

Scientific Associate Vice President
Merck & Co., Inc.
West Point, Pennsylvania

Moderator(s)

Amanda Hays, Ph.D.

Scientific Officer
BioAgilytix
Olathe, Kansas

Our ability to generate quantitative data is central to drug discovery and development. The field of Bioanalysis is rapidly evolving, ranging from new approaches for sample collection, automated/miniaturized experimentation and more complex data collection and processing. This is leading to experiments that are more personal, results that are more precise and where we have the ability to predict the experimental outcome and/or the next experiment to perform.

Learning Objectives:

Understand the concept of patient centric sampling and how access to new sample types will advance drug discovery and development
Discuss the value of enriched data sets and how they can be used to gain better insights into data quality and biological interpretation
Learn how new methods for data processing will lead to better methods and results for bioanalysis